Advanced gallbladder cancer, HER2+++

After months in the hospital, my father finally received zanidatamab.
We had followed this drug on DengYueMed for over a year.

The timing was cruel. The fever reaction was strong.
But today, he felt better, ate more, and asked for dinner.

Sometimes hope isn’t a response rate.
Sometimes it’s simply getting through the day.

#CancerCare #HER2 #GallbladderCancer #Caregiver #Zanidatamab #DengYueMed

#BeAware about #GallbladderCancer!

Did you know that gallbladder and bile duct cancers are rare but aggressive?

In 2025, the American Cancer Society estimates there will be about 12,610 new cases of gallbladder and bile duct cancers in the U.S.

Hispanic individuals are twice as likely to be diagnosed with gallbladder cancer compared to white individuals, and rates are also higher in Native American and Asian-Pacific Islander communities.

Symptoms include:+